John Roche C.'s Insider Trades & SAST Disclosures
John Roche C.'s most recent trade in Hanover Insurance Group Inc was a trade of 8,906 Common Stock done at an average price of $77.9 . Disclosure was reported to the exchange on April 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern John Roche C..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 77.91 per share. | 01 Apr 2025 | 8,906 | 133,319 (0%) | 0% | 77.9 | 693,866 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 175.17 per share. | 01 Apr 2025 | 8,906 | 124,413 (0%) | 0% | 175.2 | 1,560,064 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 8,906 | 0 | - | - | Common Stock Option (right to buy) | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 77.91 per share. | 28 Mar 2025 | 400 | 124,677 (0%) | 0% | 77.9 | 31,164 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 400 | 9,207 | - | - | Common Stock Option (right to buy) | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 175.03 per share. | 28 Mar 2025 | 400 | 124,277 (0%) | 0% | 175.0 | 70,012 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 301 | 8,906 | - | - | Common Stock Option (right to buy) | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 175.00 per share. | 28 Mar 2025 | 301 | 124,413 (0%) | 0% | 175 | 52,675 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 77.91 per share. | 28 Mar 2025 | 301 | 124,714 (0%) | 0% | 77.9 | 23,451 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2025 | 135 | 124,413 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 77.91 per share. | 26 Mar 2025 | 900 | 125,177 (0%) | 0% | 77.9 | 70,119 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2025 | 900 | 9,807 | - | - | Common Stock Option (right to buy) | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 175.17 per share. | 26 Mar 2025 | 900 | 124,277 (0%) | 0% | 175.2 | 157,653 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2025 | 200 | 9,607 | - | - | Common Stock Option (right to buy) | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 175.01 per share. | 26 Mar 2025 | 200 | 124,277 (0%) | 0% | 175.0 | 35,002 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 77.91 per share. | 26 Mar 2025 | 200 | 124,477 (0%) | 0% | 77.9 | 15,582 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 10,706 | 10,707 | - | - | Common Stock Option (right to buy) | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 77.91 per share. | 03 Mar 2025 | 10,706 | 134,983 (0%) | 0% | 77.9 | 834,104 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 172.66 per share. | 03 Mar 2025 | 5,509 | 124,277 (0%) | 0% | 172.7 | 951,184 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 171.86 per share. | 03 Mar 2025 | 3,303 | 129,786 (0%) | 0% | 171.9 | 567,654 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 170.91 per share. | 03 Mar 2025 | 1,894 | 133,089 (0%) | 0% | 170.9 | 323,704 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 22,943 | 0 | - | - | Common Stock Option (right to buy) | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.14 per share. | 27 Feb 2025 | 22,943 | 148,707 (0%) | 0% | 66.1 | 1,517,450 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 166.00 per share. | 27 Feb 2025 | 15,604 | 133,103 (0%) | 0% | 166 | 2,590,264 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 170.53 per share. | 27 Feb 2025 | 8,826 | 124,277 (0%) | 0% | 170.5 | 1,505,098 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 39,629 | 39,629 | - | - | Common Stock Option (right to buy) | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 9,554 | 115,368 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 8,652 | 125,764 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 1,744 | 117,112 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
C. John Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2024 | 143 | 105,814 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 162.52 per share. | 02 Dec 2024 | 412 | 105,671 (0%) | 0% | 162.5 | 66,958 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 05 Nov 2024 | 6,802 | 14,454 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 05 Nov 2024 | 6,802 | 107,108 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Nov 2024 | 1,025 | 106,083 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Sep 2024 | 143 | 113,910 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 167 | 113,766 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 153 | 113,599 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
Roche John C. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 41,437 | 41,437 | - | - | Common Stock Option (right to buy) | |
|
Hanover Insurance Group Inc
|
Roche C. John | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 134.61 per share. | 26 Feb 2024 | 11,233 | 104,135 (0%) | 0% | 134.6 | 1,512,074 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 9,311 | 113,446 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
C. John Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 9,120 | 109,045 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 6,322 | 115,367 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John Roche C. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 22,305 | 0 | - | - | Common Stock Option (right to buy) | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.61 per share. | 16 Feb 2024 | 22,305 | 113,978 (0%) | 0% | 54.6 | 1,218,076 | Common Stock |
|
Hanover Insurance Group Inc
|
C. Roche John | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 135.88 per share. | 16 Feb 2024 | 14,053 | 99,925 (0%) | 0% | 135.9 | 1,909,522 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 162 | 91,673 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
C. John Roche | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 125.09 per share. | 01 Dec 2023 | 686 | 91,511 (0%) | 0% | 125.1 | 85,812 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2023 | 173 | 92,197 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 168 | 92,024 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 147 | 91,855 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 36,453 | 36,453 | - | - | Common Stock Option (right to buy) | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 139.48 per share. | 27 Feb 2023 | 10,017 | 91,708 (0%) | 0% | 139.5 | 1,397,171 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 8,822 | 87,042 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 8,214 | 101,725 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 6,469 | 93,511 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.01 per share. | 24 Feb 2023 | 6,336 | 81,546 (0%) | 0% | 40.0 | 253,503 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2023 | 6,336 | 0 | - | - | Common Stock Option (right to buy) | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 139.34 per share. | 24 Feb 2023 | 3,326 | 78,220 (0%) | 0% | 139.3 | 463,445 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 130 | 75,210 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 127 | 75,079 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2022 | 109 | 74,952 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 155.24 per share. | 21 Apr 2022 | 922 | 74,843 (0%) | 0% | 155.2 | 143,133 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2022 | 922 | 6,336 | - | - | Common Stock Option (right to buy) | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.01 per share. | 21 Apr 2022 | 922 | 75,765 (0%) | 0% | 40.0 | 36,889 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Mar 2022 | 4,533 | 9,983 | - | - | Common Stock Option (right to buy) | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 150.09 per share. | 25 Mar 2022 | 4,533 | 74,843 (0%) | 0% | 150.1 | 680,355 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.01 per share. | 25 Mar 2022 | 4,533 | 79,376 (0%) | 0% | 40.0 | 181,365 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Mar 2022 | 2,725 | 7,258 | - | - | Common Stock Option (right to buy) | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 150.47 per share. | 25 Mar 2022 | 2,725 | 74,843 (0%) | 0% | 150.5 | 410,042 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.01 per share. | 25 Mar 2022 | 2,725 | 77,568 (0%) | 0% | 40.0 | 109,027 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2022 | 107 | 74,843 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2022 | 7,258 | 14,516 | - | - | Common Stock Option (right to buy) | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.01 per share. | 17 Mar 2022 | 7,258 | 81,993 (0%) | 0% | 40.0 | 290,393 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 145.65 per share. | 17 Mar 2022 | 6,193 | 75,800 (0%) | 0% | 145.7 | 902,017 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 146.21 per share. | 17 Mar 2022 | 1,065 | 74,735 (0%) | 0% | 146.2 | 155,713 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 139.52 per share. | 07 Mar 2022 | 7,565 | 74,735 (0%) | 0% | 139.5 | 1,055,469 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 34,689 | 34,689 | - | - | Common Stock Option (right to buy) | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 8,685 | 70,337 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 7,097 | 82,299 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 4,865 | 75,202 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2021 | 105 | 61,537 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 136.06 per share. | 06 Aug 2021 | 6,684 | 61,431 (0%) | 0% | 136.1 | 909,420 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.66 per share. | 06 Aug 2021 | 6,684 | 68,115 (0%) | 0% | 34.7 | 231,667 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2021 | 6,684 | 5,000 | - | - | Common Stock Option (right to buy) | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 138.00 per share. | 06 Aug 2021 | 5,000 | 61,431 (0%) | 0% | 138 | 690,000 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.66 per share. | 06 Aug 2021 | 5,000 | 66,431 (0%) | 0% | 34.7 | 173,300 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2021 | 5,000 | 0 | - | - | Common Stock Option (right to buy) | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 101 | 61,431 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2021 | 106 | 61,330 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 41,747 | 41,747 | - | - | Common Stock Option (right to buy) | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 15,288 | 59,161 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 7,586 | 66,747 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 119.67 per share. | 26 Feb 2021 | 5,523 | 61,224 (0%) | 0% | 119.7 | 660,937 | Common Stock |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Sep 2020 | 87 | 43,799 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2020 | 81 | 43,712 (0%) | 0% | 0 | Common Stock | |
|
Hanover Insurance Group Inc
|
John C. Roche | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.01 per share. | 15 May 2020 | 577 | 43,630 (0%) | 0% | 86.0 | 49,628 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges